Cure My Disease

Don't miss your cure!

 Log in / Sign up

Experimental antibody shows promise in early HIV study

NCT ID NCT02591420

Completed Disease control Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Source: ClinicalTrials.gov ↗

First seen Dec 31, 2025 · Last updated May 09, 2026 · Updated 18 times

Summary

This early-stage study tested an experimental antibody called VRC01 in 24 adults with very recent HIV infection. The goal was to see if it is safe and can lower the amount of virus in the blood, either alone or with standard HIV medications. The study found that VRC01 was generally safe, but it is not a cure and HIV management still requires ongoing treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • ECHO Center Non-Network CRS

    Chon Buri, Thailand

  • Kenya Med. Research Inst./Walter Reed Project, Clinical Research Centre, Off Hospital Road. Kericho

    Kericho, 20200, Kenya

  • Makerere University Walter Reed Project (MUWRP)

    Kampala, Uganda

  • National Institute for Medical Research (NIMR)-Mbeya Medical Research Center (MMRC) Non-Network CRS

    Mbeya, Tanzania

  • SEARCH Thai Red Cross AIDS Research Centre Non-Network CRS

    Bangkok, 10330, Thailand

Conditions

Explore the condition pages connected to this study.

HIV INFECTIONS